Dashboard
Manage Tickers

SPHDInvesco S&P 500 High Divide...


$ 50.13 $ -0.12 (-0.24 %)    

Wednesday, 18-Sep-2024 15:58:28 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ 50.12
$ 50.32
$ 50.10 x 100
-- x --
$ 50.13 - $ 50.52
$ 35.98 - $ 50.64
500,636
na
na
$ 0.91
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

3m-visa-medtronic-and-more-on-cnbcs-final-trades
3M, Visa, Medtronic And More On CNBC's 'Fi...
09/11/2024 12:16:52

Joshua Brown of Ritholtz Wealth Management named 3M Co. as his final trade on CNBC's Halftime Report, while other experts s...

Core News & Articles
CNBC Halftime Report Final Trades: Nasdaq,...
09/10/2024 17:02:27

Core News & Articles
CNBC Halftime Report Final Trades: Amazon....
08/01/2024 17:00:36

best-buys-top-line-trends-remain-pressured-says-analyst
Best Buy's Top-Line Trends Remain Pressure...
05/15/2024 18:01:16

BofA Securities' analyst, Robert F. Ohmes, maintains an Underperform rating on Best Buy, with a $70.00 price target. Despit...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION